About SyncroPhi
SyncroPhi is a company based in Sandton (South Africa) founded in 2007. SyncroPhi has raised $1.36 million across 2 funding rounds from investors including European Union and AIB Seed Capital Fund. SyncroPhi offers products and services including KEWS300. SyncroPhi operates in a competitive market with competitors including Tyto Care, Edwards Lifesciences, BioIntelliSense, Dozee and Endotronix, among others.
- Headquarter Sandton, South Africa
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Syncrophi Systems Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.36 M (USD)
in 2 rounds
-
Latest Funding Round
$493.32 K (USD), Grant
Mar 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SyncroPhi
SyncroPhi offers a comprehensive portfolio of products and services, including KEWS300.
Software for accurate vital sign monitoring and error reduction in hospitals.
Funding Insights of SyncroPhi
SyncroPhi has successfully raised a total of $1.36M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $493.32 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SyncroPhi
SyncroPhi has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and AIB Seed Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for SyncroPhi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SyncroPhi
Investment portfolio details for SyncroPhi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SyncroPhi
Detailed financials for SyncroPhi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Syncrophi Comparisons
Peer comparison for SyncroPhi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SyncroPhi
SyncroPhi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tyto Care, Edwards Lifesciences, BioIntelliSense, Dozee and Endotronix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical consultations are facilitated via self-exams and remote diagnostic devices.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Platform offering remote patient monitoring using AI-driven contactless solutions
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
Detailed competitors of SyncroPhi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Syncrophi
Complete news archive for SyncroPhi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SyncroPhi
SyncroPhi was founded in 2007 and raised its 1st funding round 6 years after it was founded.
SyncroPhi is headquartered in Sandton, South Africa. It is registered at Sandton, Gauteng, South Africa.
SyncroPhi is a funded company, having raised a total of $1.36M across 2 funding rounds to date.
Wireless vital signs monitoring system and paperless observation records. Its offerings include KEWS 100, small lightweight sensor modules worn in a disposable pouch that gives the patient freedom to move and give the staff the ability to provide continuous monitoring of body vitals, and KEWS 200, a wireless ambulatory patient vital-signs monitoring with paperless observation records and instant patient review at the point of care, KEWS 300 a CE-marked software suite which supports paperless patient observation rounds and clinical reviews at the point-of-care. When combined with the KEWSpod it provides real-time updates of patient records and instant recall of patient history.
SyncroPhi's top competitors include Tyto Care, Dozee and Endotronix.
SyncroPhi offers KEWS300.
SyncroPhi has 2 investors. Key investors include European Union, and AIB Seed Capital Fund.